Details of the Drug | DrugMAP

General Information of Drug (ID: DMCB0D6)

Drug Name	PMID29473428-Compound-14
Drug Type	Small molecular drug
Structure
Structure	3D MOL			2D MOL
#Ro5 Violations (Lipinski): 0	Molecular Weight (mw)			197.62
	Logarithm of the Partition Coefficient (xlogp)			2
	Rotatable Bond Count (rotbonds)			0
	Hydrogen Bond Donor Count (hbonddonor)			1
	Hydrogen Bond Acceptor Count (hbondacc)			4
Chemical Identifiers	Formula C8H8ClN3O IUPAC Name 5-chloro-4,6-dimethyl-[1,2]oxazolo[5,4-b]pyridin-3-amine Canonical SMILES CC1=C2C(=NOC2=NC(=C1Cl)C)N InChI InChI=1S/C8H8ClN3O/c1-3-5-7(10)12-13-8(5)11-4(2)6(3)9/h1-2H3,(H2,10,12) InChIKey XEYWCHKONZUDGB-UHFFFAOYSA-N
Cross-matching ID	PubChem CID 5305899 TTD ID D0L8KM

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Indoleamine 2,3-dioxygenase 1 (IDO1)	TTZJYKH	I23O1_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	A patent review of IDO1 inhibitors for cancer.Expert Opin Ther Pat. 2018 Apr;28(4):317-330.